Skip to main content
Premium Trial:

Request an Annual Quote

Pfizer Renews Subscription to GeneLogic s ToxExpress Database, Adds ToxShield

NEW YORK, Aug. 11 (GenomeWeb News) - Pfizer has renewed its subscription to Gene Logic's ToxExpress database of gene expression profiles and clinical data, Gene Logic said yesterday.

 

In addition, Pfizer has subscribed to Gene Logic's ToxShield software for assessing and ranking drug candidates based on their potential toxicity in humans.

 

Gene Logic also provides microarray services to Pfizer -- a program launched in March -- to determine potentially toxic effects of novel compounds on tissues of interest.

 

Pfizer has been a subscriber to Gene Logic's ToxExpress database since February 2000. Its renewed subscription runs for three years.

 

The companies did not disclose the financial terms of the subscriptions.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.